
Be curious! Web3 & LocalAI @Elacityofficial @ElastosInfo
- Tweets10.4K
- Following1.9K
- Followers2.9K
- Likes19.6K

ALT Chart: Mithril Medicine, a rare-disease biotech, before Anthropic acquired it in July 2026. 1 full-time employee (the founder), 11 external labs coordinated with help from Claude, 8 paid consultants and advisers, under 18 months from idea to promising results in mice. Sources: Anthropic and R&D World, Oct 27, 2026. Results are preclinical.

ALT A neurology record, priced. From Tempus AI's Form 8-K dated 23 Oct 2026: $100 per delivered de-identified record of patients with Alzheimer's or other specified neurological conditions, licensed to Pathos AI. A bar chart shows records to be delivered cumulatively at 100,000 a year, reaching 500,000 in year 5. Parties: Tempus, Pathos AI, Bristol-Myers Squibb (side letter). No patient is a party. Up to $55M: $50M in record fees plus $5M for record updates. Delivery is on commercially reasonable efforts over a five-year term.



















